Analysts on Wall Street expect Merck (MRK) to report strong quarterly earnings and revenue growth. Consensus estimates project earnings per share (EPS) of $2.01, representing a 43.6% increase year-over-year. Revenue is projected to reach $15.34 billion, a 5.9% increase compared to the same quarter last year. Over the past 30 days, the consensus EPS estimate has been revised up by 7%, indicating analysts’ growing optimism about the company’s performance. Analysts’ projections for specific key metrics provide further insights into Merck’s business dynamics.